ACTIVE

HASHIMOTO

Financial year 2024 · closed on 31/12/2024
Net result
0 €
-100.0% YoY
Gross margin
12,2 k €
-35.1% YoY
Equity
10,8 k €
0.0% YoY

What does HASHIMOTO do?

HASHIMOTO is a Private limited company incorporated in 2021. Its main activity is: Specialist medical practice activities. Its registered office is in Roeselare.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0779.364.910
Incorporation
24/12/2021
Legal form
Private limited company
Registered office
Deltalaan 1
8800 Roeselare · FlandreSee on map
Contributed capital
10 810,80 €
Latest accounts
31/12/2024
Signals
Positive cashflowPositive EBITDAHealthy social debts
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202420232022
Income statement
Gross margin12,2 k €18,9 k €1,5 k €
EBITDA8,5 k €17,2 k €-150,8 €
Operating result140,2 €8,9 k €-183,1 €
Net result0 €8,6 k €
Balance sheet
Equity10,8 k €10,8 k €10,8 k €
Total assets1,1 M €1,1 M €1 M €
Cash202,9 k €172,2 k €271,3 k €
Debts1,1 M €1,1 M €1 M €
Estimate

Indicative valuation

As an indication, this company is worth

between 100 k€ and 250 k€
See the valuation
Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 8 ended

Active mandates

REIVAX MD

Director · since 24 janvier 2024 · 1005.195.162

Represented by Xavier-Philippe Aers

Active
DOKTER JAN VAN DEN SAFFELE

Director · 0893.322.686

Represented by Jan Van Den Saffele

Active
KASP

Managing director · 0831.409.566

Represented by Katrien Spincemaille

Active
PENIJULLINE

Managing director · 0692.832.297

Represented by Francis Duyck

Active
Xavier-Philippe Aers

Director · until 24 janvier 2024

Active

Ended mandates

REIVAX MD

Director · since 24 janvier 2024 · 1005.195.162

Represented by Xavier-Philippe AERS

Ended
DOKTER JAN VAN DEN SAFFELE

Managing director · since 22 décembre 2021 · 0893.322.686

Represented by Jan Van Den Saffele

Ended
KASP

Managing director · since 22 décembre 2021 · 0831.409.566

Represented by Katrien Spincemaille

Ended
PENIJULLINE

Director · since 22 décembre 2021 · 0692.832.297

Represented by Francis Duyck

Ended
At this address

Other companies at this address

CompanyCBE no.
AddisonActive
1015.428.365
0505.931.808
0723.701.459
0754.940.706
0689.980.004
0742.828.374
0781.379.342
1024.732.249
0775.493.026
0536.693.377
0770.509.404
AZ DELTA-MKAActive
0801.278.594
BloodXpertActive
1016.346.105
0762.948.451
0545.787.128
0742.882.121
Delta LongActive
1015.125.091
0886.898.714
0722.918.333
0722.670.982
Annual accounts

Full financial information

202420232022
Type of accountAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202401/01/202324/12/2021
Closing of the financial year31/12/202431/12/202331/12/2022
Length of the financial year12 months12 months13 months
Filing date14/07/202524/07/202417/07/2023
General meeting30/06/202524/06/202426/06/2023
Currency of the financial yearEUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

3 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202430/06/202514/07/2025DutchPDF
Abridged model31/12/202324/06/202424/07/2024DutchPDF
Abridged model31/12/202226/06/202317/07/2023DutchPDF
Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 100 k€ and 250 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 5 active · 8 ended

Active mandates

REIVAX MD

Director · since 24 janvier 2024 · 1005.195.162

Represented by Xavier-Philippe Aers

Active
DOKTER JAN VAN DEN SAFFELE

Director · 0893.322.686

Represented by Jan Van Den Saffele

Active
KASP

Managing director · 0831.409.566

Represented by Katrien Spincemaille

Active
PENIJULLINE

Managing director · 0692.832.297

Represented by Francis Duyck

Active
Xavier-Philippe Aers

Director · until 24 janvier 2024

Active

Ended mandates

REIVAX MD

Director · since 24 janvier 2024 · 1005.195.162

Represented by Xavier-Philippe AERS

Ended
DOKTER JAN VAN DEN SAFFELE

Managing director · since 22 décembre 2021 · 0893.322.686

Represented by Jan Van Den Saffele

Ended
KASP

Managing director · since 22 décembre 2021 · 0831.409.566

Represented by Katrien Spincemaille

Ended
PENIJULLINE

Director · since 22 décembre 2021 · 0692.832.297

Represented by Francis Duyck

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Mandates13/05/2024
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other28/12/2021
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2024
    Annual accounts 20240 €
  2. 2023
    Annual accounts 20238,6 k €
  3. 2022
    Annual accounts 2022
  4. 24/12/2021
    IncorporationPrivate limited company